Skip to main content
Log in

Autoimmune cholangitis: A variant of primary biliary cirrhosis

Clinicopathologic and serologic correlations in 200 cases

  • Liver: Cirrhosis, Fibrosis, Portal Hypertension, And Transplantation
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The term “autoimmune cholangitis” is used for a disease with clinical and pathologic features of primary biliary cirrhosis (PBC) but with negative anti-mitochondrial antibody (AMA) and positive anti-nuclear antibody (ANA) tests. In order to characterize autoimmune cholangitis and to determine whether this truly differs from PBC, we reviewed 200 cases morphologically consistent with PBC in which data on AMA and ANA status were available to us. Of these, 64 (32%) had a negative AMA, 114 (57%) had a positive ANA, and 40 (20%) had negative AMA and positive ANA (autoimmune cholangitis). The AMA-negative group was slightly younger on average (50 vs 55 years) than AMA positives (P<0.05). There were no significant differences in gender (15.5% male overall), hepatic histopathology, or other laboratory tests between the groups of patients with any of the 4 possible combinations of AMA and ANA. Since the only consistently distinguishing feature among these patients is the autoantibody (AMA and ANA) profile, and they otherwise have virtually identical clinical and histopathologic features, autoimmune cholangitis can be considered to be the same as AMA-negative PBC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brunner G, Klinge O: Ein der chronisch-destruierenden nicht-eitrigen Cholangitis ähnliches Krankheitsbild mit antinukleären Antikörpern (Immunocholangitis). Dtsch Med Wochenschr 112:1454–1458, 1987

    PubMed  Google Scholar 

  2. Michieletti P, Wanless IR, Katz A, Scheuer PJ, Yeaman SJ, Bassendine MF, Palmer JM, Heathcote EJ: Antimitochondrial antibody negative primary biliary cirrhosis: A distinct syndrome of autoimmune cholangitis. Gut 35:260–265, 1994

    PubMed  Google Scholar 

  3. Taylor SL, Dean PJ, Riely CA: Primary autoimmune cholangitis: An alternative to antimitochondrial antibody-negative primary biliary cirrhosis. Am J Surg Pathol 18:91–99, 1994

    PubMed  Google Scholar 

  4. Lacerda MA, Lindor KD, Jorgensen RA, Ludwig J, Dickson ER: “Autoimmune cholangitis” better defines antimitochondrial antibody negative primary biliary cirrhosis. Gastroenterology 104 :A933, 1993

  5. Ben-Ari Z, Dhillon AP, Sherlock S: Autoimmune cholangiopathy: Part of the spectrum of autoimmune chronic active hepatitis. Hepatology 18:10–15, 1993

    PubMed  Google Scholar 

  6. Portmann B, Popper H, Neuberger J, Williams R: Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients. Gastroenterology 88:1777–1790, 1985

    PubMed  Google Scholar 

  7. Carrougher JG, Shaffer RT, Canales LI, Goodman ZD: Diagnostic problems in clinical hepatology: A 33-year-old woman with an autoimmune syndrome. Semin Liv Dis 11:256–262, 1991

    Google Scholar 

  8. Maddrey WC: Chronic hepatitis:In Hepatology: A Textbook of Liver Disease, 2nd ed. D Zakim, TD Boyer (eds). Philadelphia, WB Saunders, 1989, pp 1025–1061

    Google Scholar 

  9. Boyer JL, Reuben A: Chronic hepatitis.In Diseases of the Liver, 7th ed. L Schiff ER Schiff (eds). Philadelphia, JB Lippincott, 1993, pp 586–537

    Google Scholar 

  10. Vierling JM: Primary biliary cirrhosis.In Hepatology: A Textbook of Liver Disease, 2nd ed. D Zakim, TD Boyer (eds). Philadelphia, WB Saunders, 1989, pp 1158–1205

    Google Scholar 

  11. Kaplan MM: Primary biliary cirrhosis.In Diseases of the Liver, 7th ed. L Schiff, ER Schiff (eds). Philadelphia, JB Lippincott, 1993, pp 377–410

    Google Scholar 

  12. Hashimoto E, Lindor KD, Homburger HA, Dickson ER, Czaja AJ, Wiesner RH, Ludwig J: Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Mayo Clin Proc 68:1049–1055, 1993

    PubMed  Google Scholar 

  13. Nakanuma Y: Necroinflammatory changes in hepatic lobules in primary biliary cirrhosis with less well-defined cholestatic changes. Hum Pathol 24:378–383, 1993

    PubMed  Google Scholar 

  14. Vyberg M: The hepatitis-associated bile duct lesion. Liver 13:289–301, 1993

    PubMed  Google Scholar 

  15. Fukusato T, Gerber MA, Thung SN, Ferrone S, Schaffner F: Expression of HLA class I antigens on hepatocytes in liver disease. Am J Pathol 123:264–270, 1986

    PubMed  Google Scholar 

  16. Franco A, Barnaba V, Natali P, Balsano C, Musca A, Balsano F: Expression of class I and class II major histocompatibility complex antigens on human hepatocytes. Hepatology 8:449–454, 1988

    PubMed  Google Scholar 

  17. Calmus Y, Gane P, Rouger P, Poupon R: Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: Effect of ursodeoxycholic acid. Hepatology 11:12–15, 1990

    PubMed  Google Scholar 

  18. Seeff LB: Drug-induced chronic liver disease, with emphasis on chronic active hepatitis. Semin Liv Dis 1:104–115, 1981

    Google Scholar 

  19. Lewis JH, Zimmerman HJ: Drug-induced liver disease. Med Clin North Am 73:775–792, 1989

    PubMed  Google Scholar 

  20. Degott C, Feldman G, Larrey D, Durand-Schneider AM, Grange D, Machayekhi JP, Moreau A, Potet F, Benhamou JP: Drug-induced prolonged cholestasis in adults: A histological semiquantitative study demonstrating progressive ductopenia. Hepatology 15:244–251, 1992

    PubMed  Google Scholar 

  21. Klöppel G, Seifert G, Lindner H, Dammerman R, Sack HJ, Berg PA: Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis. Virchows Arch A Path Anat Histol 373:143–160, 1977

    Google Scholar 

  22. Okuno T, Seto Y, Okanoue T, Takino T: Chronic active hepatitis with histological features of primary biliary cirrhosis. Dig Dis Sci 32:775–779, 1987

    PubMed  Google Scholar 

  23. Davis PA, Leung P, Manns M, Kaplan M, Munoz SJ, Gorin FA, Dickson ER, Krawitt E, Coppel R, Gershwin ME: M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: Epitopes or epiphenomena? Hepatology 16:1128–1136, 1992

    PubMed  Google Scholar 

  24. Berg PA, Klein R: Autoantibody patterns in primary biliary cirrhosis.In Autoimmune Liver Disease. EL Krawitt, RH Wiesner (eds). New York, Raven Press, 1991, pp 123–142

    Google Scholar 

  25. Mitchison HC, Bassendine MF, Malcolm AJ, Watson AJ, Record CO, James OW: A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: Hepatic improvement but greater bone loss. Hepatology 10:420–429, 1989

    PubMed  Google Scholar 

  26. Rubin E, Schaffner F, Popper H: Primary biliary cirrhosis: Chronic nonsuppurative destructive cholangitis. Am J Pathol 46:387–407, 1965

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goodman, Z.D., McNally, P.R., Davis, D.R. et al. Autoimmune cholangitis: A variant of primary biliary cirrhosis. Digest Dis Sci 40, 1232–1242 (1995). https://doi.org/10.1007/BF02065530

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02065530

Key words

Navigation